BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23530645)

  • 1. Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474).
    Mason JK; Fu MH; Chen J; Yu Z; Thompson LU
    Nutr Cancer; 2013; 65(3):451-9. PubMed ID: 23530645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474).
    Mason JK; Fu M; Chen J; Thompson LU
    J Nutr Biochem; 2015 Jan; 26(1):16-23. PubMed ID: 25441844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flaxseed oil-trastuzumab interaction in breast cancer.
    Mason JK; Chen J; Thompson LU
    Food Chem Toxicol; 2010; 48(8-9):2223-6. PubMed ID: 20580760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Mol Nutr Food Res; 2010 Mar; 54(3):415-25. PubMed ID: 19904759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen.
    Truan JS; Chen JM; Thompson LU
    Mol Nutr Food Res; 2010 Oct; 54(10):1414-21. PubMed ID: 20425756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice.
    Truan JS; Chen JM; Thompson LU
    Nutr Cancer; 2012; 64(1):65-71. PubMed ID: 22136581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary flaxseed interaction with tamoxifen induced tumor regression in athymic mice with MCF-7 xenografts by downregulating the expression of estrogen related gene products and signal transduction pathways.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Nutr Cancer; 2007; 58(2):162-70. PubMed ID: 17640162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen.
    Chen J; Power KA; Mann J; Cheng A; Thompson LU
    Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.
    Chen J; Saggar JK; Corey P; Thompson LU
    Br J Nutr; 2011 Feb; 105(3):339-47. PubMed ID: 21138602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways.
    Saggar JK; Chen J; Corey P; Thompson LU
    Nutr Cancer; 2010; 62(4):533-42. PubMed ID: 20432175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary flaxseed enhances the inhibitory effect of tamoxifen on the growth of estrogen-dependent human breast cancer (mcf-7) in nude mice.
    Chen J; Hui E; Ip T; Thompson LU
    Clin Cancer Res; 2004 Nov; 10(22):7703-11. PubMed ID: 15570004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and therapeutic options for the treatment of raloxifene-stimulated breast cancer in athymic mice.
    O'Regan RM; Osipo C; Ariazi E; Lee ES; Meeke K; Morris C; Bertucci A; Sarker MA; Grigg R; Jordan VC
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2255-63. PubMed ID: 16609042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary flaxseed inhibits human breast cancer growth and metastasis and downregulates expression of insulin-like growth factor and epidermal growth factor receptor.
    Chen J; Stavro PM; Thompson LU
    Nutr Cancer; 2002; 43(2):187-92. PubMed ID: 12588699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-linolenic acid and docosahexaenoic acid, alone and combined with trastuzumab, reduce HER2-overexpressing breast cancer cell growth but differentially regulate HER2 signaling pathways.
    Mason JK; Klaire S; Kharotia S; Wiggins AK; Thompson LU
    Lipids Health Dis; 2015 Aug; 14():91. PubMed ID: 26282560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HER2-positive breast cancer cells resistant to trastuzumab and lapatinib lose reliance upon HER2 and are sensitive to the multitargeted kinase inhibitor sorafenib.
    Valabrega G; Capellero S; Cavalloni G; Zaccarello G; Petrelli A; Migliardi G; Milani A; Peraldo-Neia C; Gammaitoni L; Sapino A; Pecchioni C; Moggio A; Giordano S; Aglietta M; Montemurro F
    Breast Cancer Res Treat; 2011 Nov; 130(1):29-40. PubMed ID: 21153051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical antitumor activity of the novel heat shock protein 90 inhibitor CH5164840 against human epidermal growth factor receptor 2 (HER2)-overexpressing cancers.
    Ono N; Yamazaki T; Nakanishi Y; Fujii T; Sakata K; Tachibana Y; Suda A; Hada K; Miura T; Sato S; Saitoh R; Nakano K; Tsukuda T; Mio T; Ishii N; Kondoh O; Aoki Y
    Cancer Sci; 2012 Feb; 103(2):342-9. PubMed ID: 22050138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flaxseed attenuates the tumor growth stimulating effect of soy protein in ovariectomized athymic mice with MCF-7 human breast cancer xenografts.
    Saarinen NM; Power K; Chen J; Thompson LU
    Int J Cancer; 2006 Aug; 119(4):925-31. PubMed ID: 16557589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed.
    Power KA; Chen JM; Saarinen NM; Thompson LU
    J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):13-9. PubMed ID: 18703142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-FDG small-animal PET/CT differentiates trastuzumab-responsive from unresponsive human breast cancer xenografts in athymic mice.
    McLarty K; Fasih A; Scollard DA; Done SJ; Vines DC; Green DE; Costantini DL; Reilly RM
    J Nucl Med; 2009 Nov; 50(11):1848-56. PubMed ID: 19837760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.